We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+17.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
98.65%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$7.42M |
| 2 |
Vericel Corp
VCEL
|
+$4.58M |
| 3 |
Veracyte
VCYT
|
+$4.15M |
| 4 |
Idexx Laboratories
IDXX
|
+$4.14M |
| 5 |
CareDx
CDNA
|
+$4.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.3% |
| 2 | Technology | 12.81% |
| 3 | Communication Services | 6.99% |
| 4 | Industrials | 4.39% |
| 5 | Consumer Staples | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STRM
51
DELISTED
Streamline Health Solutions
STRM
| $677K | 0.62% |
+28,917
| New | +$605K |
|
|
ATRS
52
DELISTED
Antares Pharma, Inc.
ATRS
| $612K | 0.56% |
+226,533
| New | +$627K |
|
53
CryoPort
CYRX
$754M
| $569K | 0.52% |
+12,000
| New | +$486K |
|
54
Apple
AAPL
$4.57T
| $556K | 0.51% |
+4,800
| New | +$524K |
|
55
DNA X Inc
SONM
$5.7M
| $466K | 0.43% |
+333
| New | +$535K |
|
56
Intel
INTC
$520B
| $453K | 0.42% |
+8,750
| New | +$455K |
|
57
Donaldson
DCI
$11.2B
| $444K | 0.41% |
+9,567
| New | +$465K |
|
58
General Mills
GIS
$19.3B
| $439K | 0.4% |
+7,125
| New | +$445K |
|
59
ePlus
PLUS
$2.38B
| $439K | 0.4% |
+12,000
| New | +$446K |
|
60
Fastenal
FAST
$58B
| $433K | 0.4% |
+19,200
| New | +$441K |
|
|
ITMR
61
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $409K | 0.38% |
+20,000
| New | +$449K |
|
62
CVS Health
CVS
$123B
| $386K | 0.35% |
+6,609
| New | +$411K |
|
63
Baxter International
BAX
$14.4B
| $351K | 0.32% |
+4,367
| New | +$367K |
|
|
IIN
64
DELISTED
IntriCon Corporation
IIN
| $341K | 0.31% |
+28,025
| New | +$341K |
|
65
H.B. Fuller
FUL
$3.21B
| $339K | 0.31% |
+7,400
| New | +$350K |
|
66
Dyadic International
DYAI
$36.4M
| $322K | 0.3% |
+42,500
| New | +$351K |
|
67
US Bancorp
USB
$100B
| $320K | 0.29% |
+8,917
| New | +$326K |
|
68
NXP Semiconductors
NXPI
$59.3B
| $318K | 0.29% |
+2,550
| New | +$311K |
|
69
Crexendo
CXDO
$218M
| $307K | 0.28% |
+55,000
| New | +$443K |
|
70
Bionano Genomics
BNGO
$12.6M
| $306K | 0.28% |
+783
| New | +$304K |
|
|
BIOL
71
DELISTED
Biolase, Inc.
BIOL
| $306K | 0.28% |
+444
| New | +$416K |
|
72
Medtronic
MDT
$110B
| $270K | 0.25% |
+2,600
| New | +$261K |
|
|
PRFT
73
DELISTED
Perficient Inc
PRFT
| $256K | 0.24% |
+6,000
| New | +$242K |
|
74
IRIDEX
IRIX
$14.6M
| $204K | 0.19% |
+103,846
| New | +$215K |
|
75
Airgain
AIRG
$73.3M
| $180K | 0.17% |
+13,500
| New | +$173K |
|
Similar funds
PWP
BF
HWMG
WT
BAM
WLG
PA
STFP
Perkins Capital Management's Q3 2020 Portfolio in Review
Q3 2020 is the first quarter with a 13F filing on record for Perkins Capital Management, which disclosed 93 positions worth $109M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is NeoGenomics: 199,525 shares worth $7.36M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2020 buy was NeoGenomics: 199,525 shares worth $7.36M.
- Perkins Capital Management's ten largest holdings make up 40% of its $109M portfolio in Q3 2020.
- Perkins Capital Management disclosed 93 positions in Q3 2020, its first 13F filing on record.
Based on Perkins Capital Management's 13F filing for Q3 2020, filed 28 Oct 2020.